Form 4: Teladoc Health Executive Carlos Nueno Reports Stock Transactions
SEC Form 4 Filing
Carlos Nueno, President, International at Teladoc Health, reports the acquisition and disposal of Teladoc Health common stock and derivative securities.
Summary
- Carlos Nueno, President, International of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
- On February 28, 2025, Nueno acquired 1,123 shares of common stock through the conversion of restricted stock units and 3,100 shares through the conversion of restricted stock units and 1,056 shares through the conversion of performance stock units.
- On March 3, 2025, Nueno sold 2,347 shares of common stock at a price of $9.684 per share to cover tax obligations related to vesting stock units.
- As of March 3, 2025, Nueno directly owns 2,932 shares of Teladoc Health common stock.
- On March 1, 2025, Nueno was granted 104,602 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing primarily reflects routine stock transactions related to vesting and tax obligations. The granting of additional restricted stock units is a slightly positive signal.
Positives
- The granting of 104,602 restricted stock units to Carlos Nueno on March 1, 2025, indicates a continued investment in his role at Teladoc Health.
Negatives
- The sale of 2,347 shares on March 3, 2025, might be perceived negatively, although it was explicitly stated to cover tax obligations.
Risks
- Executive stock sales, even for tax purposes, can sometimes be misinterpreted by the market.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions reported in this filing may be of interest to Teladoc Health shareholders as they provide insight into the actions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 13,475 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | Reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 02/28/2025 | Date of multiple transactions involving common stock and derivative securities. |
| 03/01/2025 | Reporting person was granted 104,602 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2025 | Date of sale of 2,347 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.